U.S. Appeals Court Finds Astra’s Seroquel XR Patent Infringed

A U.S. appeals court upheld a lower court ruling that found the formulation patent for AstraZeneca’s anti-psychotic drug Seroquel XR was valid and had been infringed by Mylan and other companies seeking to sell generic versions of the medicine.
Reuters